Skip to main content
. 2020 Jun 12;48(6):0300060520925693. doi: 10.1177/0300060520925693

Table 1.

Results of the analysis of stool specimens from patients.

Patient 1 Patient 2
Pre-transplant Clostridium difficile-negative
Candida albicans
Enterococcus faecalis (S)
Clostridium difficile-negative
Enterococcus faecium (S)
Enterococcus faecalis HLGR
Post-transplant GvHD Clostridium difficile-negative
Candida albicans (S)
Klebsiella pneumoniae (ESBL+)
Enterococcus faecalis (S)
Escherichia coli ESBL+
C. difficile-negative
Enterobacter cloacae ESBL+
Klebsiella pneumoniae (S)
Candida albicans (S),
Candida parapsilosis (S-voriconazole, R-fluconazole, anidulafungin)
Post 1st FMT Escherichia coli (S)
Klebsiella pneumoniae MDR
Candida albicans
Enterococcus faecium HLGR
Candida albicans (S)
Candida parapsilosis
(S – voriconazole, R – fluconazole, anidulafungin)
Stenotrophomonas maltophilia
(S – trimethoprim/
sulfamethoxazole),
Klebsiella pneumoniae (S)
Post 2nd FMT Enterococcus faecium GRE***
Klebsiella pneumoniae PDR****
Acinetobacter baumannii MDR*****
Candida albicans
Stenotrophomonas maltophilia
(S- trimethoprim/
sulfamethoxazole)
Enterococcus faecium VRE
Candida albicans
Post 3rd FMT Klebsiella pneumoniae (S)
Candida albicans (S)
Acinetobacter baumannii MDR*****
Escherichia coli ESBL+
Enterococcus faecium VRE
Candida albicans
Post 4th FMT Not done Escherichia coli (S)
Citrobacter freundii (S)

FMT, fecal microbiota transplantation; S, susceptible to all tested antibiotics; R, resistant to at least one of the tested drugs; GvHD, graft-versus host disease, ESBL+, extended-spectrum beta-lactamase positive; MDR, multidrug-resistant; PDR, pan-drug-resistant; HLGR, high-level aminoglycoside-resistant

E. coli ESBL+ *(S – netilmicin, meropenem, ertapenem, piperacillin/tazobactam, gentamicin, amikacin; R – ciprofloxacin, cefuroxime, ceftazidime, ampicillin/sulbactam, levofloxacin, trimethoprim/sulfamethoxazole), Klebsiella pneumoniae MDR** – all, S – colistin, imipenem, tigecycline), Enterococcus faecium GRE*** (R – ampicillin, imipenem, vancomycin, teicoplanin, gentamicin, S – linezolid), Klebsiella pneumoniae PDR* (R – all, S – colistin), Enterococcus faecium HLGR (S – vancomycin, teicoplanin, linezolid, R – ampicillin, imipenem, gentamicin), Acinetobacter baumannii MDR***** – all, S – colistin, tobramycin), Enterobacter cloacae ESBL+ (R – all, S – meropenem, ertapenem, imipenem, colistin).